CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice (Q45723014)

15 December 2017

title

CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice (English)

1 reference

15 December 2017

2

1 reference

15 December 2017

4

1 reference

15 December 2017

1

Jennifer L Harcourt

1 reference

15 December 2017

3

Larry J Anderson

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

15 December 2017

1 reference

15 December 2017

volume

21

1 reference

15 December 2017

issue

21-22

1 reference

15 December 2017

page(s)

2964-2979

1 reference

Viral Respiratory Infections in the Institutionalized Elderly: Clinical and Epidemiologic Findings

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV). A meeting report of the WHO Programme for Vaccine Development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Immunity to and frequency of reinfection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Respiratory viral infections in immunocompetent and immunocompromised persons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

A role for immune complexes in enhanced respiratory syncytial virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Respiratory syncytial virus can tolerate an intergenic sequence of at least 160 nucleotides with little effect on transcription or replication in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Respiratory syncytial virus vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Protection against respiratory syncytial virus infection by DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

The immune system in the elderly: III. Innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

The immune system in the elderly: II. Specific cellular immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

The immune system in the elderly: I. Specific humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

The incidence, natural history and associated outcomes of influenza-like illness and clinical influenza in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Age associated decline in CD25 and CD28 expression correlate with an increased susceptibility to CD95 mediated apoptosis in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Functional properties of CD4+ CD28- T cells in the aging immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Immune dysregulation in the aging human lung

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Dysregulation between TH1 and TH2 T cell subpopulations in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

T cell chemokine receptor expression in aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Age-dependent defects in TCR-triggered cytoskeletal rearrangement in CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Efficacy of an inactivated respiratory syncytial virus vaccine in calves

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

An aged mouse model for RSV infection and diminished CD8(+) CTL responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Plasmids encoding granulocyte-macrophage colony-stimulating factor and CD154 enhance the immune response to genetic vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Antigenic analysis of chimeric and truncated G proteins of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

High-efficiency transduction of freshly isolated human tumor cells using adenoviral interleukin-2 vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Mice lacking CD8+ T cells develop greater numbers of IgA-producing cells in response to a respiratory virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Respiratory syncytial virus infection of gene gun vaccinated mice induces Th2-driven pulmonary eosinophilia even in the absence of sensitisation to the fusion (F) or attachment (G) protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines: involvement of IFN-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Clinical relevance of age-related immune dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Cytokines and immunity to viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Immune effects and mechanisms of action of CpG motifs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

CpG DNA as a Th1 trigger

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Establishment and persistence of virus-specific CD4+ and CD8+ T cell memory

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

CD8+ T-cell memory to viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

From naive to memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

T-cell memory: the connection between function, phenotype and migration pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Generation and maintenance of memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Response of naïve and memory CD8+ T cells to antigen stimulation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Population biology of lymphocytes: the flight for survival

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900119-1

7 January 2021

10.1016/S0264-410X(03)00119-1

Identifiers

DOI

1 reference

release_jdqd77rsa5covj2j5q2aztsbdy

15 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jdqd77rsa5covj2j5q2aztsbdy

24 November 2022

mapped directly with Wikidata item

1 reference